| 000 | 01678 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516080705.0 | ||
| 264 | 0 | _c20120905 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1538-3652 | ||
| 024 | 7 |
_a10.1001/archdermatol.2011.3320 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatsukura, Setsuko | |
| 245 | 0 | 0 |
_aEffect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients. _h[electronic resource] |
| 260 |
_bArchives of dermatology _cJun 2012 |
||
| 300 |
_a734-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPemphigus _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKnowles, Sandra R | |
| 700 | 1 | _aWalsh, Scott | |
| 700 | 1 | _aShear, Neil H | |
| 773 | 0 |
_tArchives of dermatology _gvol. 148 _gno. 6 _gp. 734-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archdermatol.2011.3320 _zAvailable from publisher's website |
| 999 |
_c21561619 _d21561619 |
||